This was a great overview of the benefits and challenges with each approach. I’ve always been confused why this is an either/or conversation rather than looking at models that allow for decriminalization and a legalization path for therapeutic models. The decrimin path would keep the legal path in check, ensuring accessibility and undermining an artificially constrained market tendencies of “extract maximum profits” of the legalization-only model. This could commodify the substance itself, prioritizing costs for the therapeutic support that some but not all would need.
This was a great overview of the benefits and challenges with each approach. I’ve always been confused why this is an either/or conversation rather than looking at models that allow for decriminalization and a legalization path for therapeutic models. The decrimin path would keep the legal path in check, ensuring accessibility and undermining an artificially constrained market tendencies of “extract maximum profits” of the legalization-only model. This could commodify the substance itself, prioritizing costs for the therapeutic support that some but not all would need.